Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism
Lisa M Caronia, Andrew A Dwyer, Douglas Hayden, Francesca Amati, Nelly Pitteloud, Frances J Hayes, Lisa M Caronia, Andrew A Dwyer, Douglas Hayden, Francesca Amati, Nelly Pitteloud, Frances J Hayes
Abstract
Objective: This study examines the physiological impact of a glucose load on serum testosterone (T) levels in men with varying glucose tolerance (GT).
Design: Cross-sectional study.
Patients and methods: 74 men (19-74 years, mean 51·4 ± 1·4 years) underwent a standard 75-g oral glucose tolerance test with blood sampling at 0, 30, 60, 90 and 120 min. Fasting serum glucose, insulin, total T (and calculated free T), LH, SHBG, leptin and cortisol were measured.
Results: 57% of the men had normal GT, 30% had impaired GT and 13% had newly diagnosed type 2 diabetes. Glucose ingestion was associated with a 25% decrease in mean T levels (delta = -4·2 ± 0·3 nm, P < 0·0001). T levels remained suppressed at 120 min compared with baseline (13·7 ± 0·6 vs 16·5 ± 0·7 nm, P < 0·0001) and did not differ across GT or BMI. Of the 66 men with normal T levels at baseline, 10 (15%) had levels that decreased to the hypogonadal range (<9·7 nm) at one or more time points. SHBG, LH and cortisol levels were unchanged. Leptin levels decreased from baseline at all time points (P < 0·0001).
Conclusions: Glucose ingestion induces a significant reduction in total and free T levels in men, which is similar across the spectrum of glucose tolerance. This decrease in T appears to be because of a direct testicular defect, but the absence of compensatory changes in LH suggests an additional central component. Men found to have low nonfasting T levels should be re-evaluated in the fasting state.
Trial registration: ClinicalTrials.gov NCT00433173.
© 2012 Blackwell Publishing Ltd.
Source: PubMed
Próximos ensaios clínicos
-
NCT07631273Ainda não está recrutandoDiabetes Mellitus | Periodontite | Ácido hialurônico | Microbiota oral | IL-34 | β-CTX
-
NCT07631286RecrutamentoPróstata aumentada (HPB) | Próstata aumentada com sintomas do trato urinário inferior
-
NCT07631299Ainda não está recrutandoCâncer de Pulmão de Células Não Pequenas Estágio I | Câncer de Pulmão de Células Não Pequenas Estágio II
-
NCT07631325Ainda não está recrutandoMelanoma cutâneo irressecável
-
NCT07631338RecrutamentoGlioma de baixo grau
-
NCT07631364Ainda não está recrutandoNeisseria Gonorrhoeae (Ng) Infections
-
NCT07631377Ainda não está recrutandoInfecções do Trato Respiratório | Pneumonia | Sons Respiratórios | Tuberculose Pulmonar | Bronquiolite | Cepa resistente a antibióticos
-
NCT07631416Ainda não está recrutandoPost op Pain in Hip Surgeries
-
NCT07631429Ainda não está recrutandoDoença grave | Composição do corpo | Obesidade e Sobrepeso | Mortalidade em Unidades de Terapia Intensiva
-
NCT07631468Ainda não está recrutandoCirurgia de mama
-
NCT07631494Ainda não está recrutandoQualidade do Sono | Delirium na Unidade de Terapia Intensiva
-
NCT07631507Ainda não está recrutandoBronquiectasia | DPOC | Doença Pulmonar Intersticial (DPI) | Obstrução das Vias Aéreas Superiores | Doenças Respiratórias Crônicas | Asma (diagnóstico)